NCT05226767View on ClinicalTrials.gov

Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 30, 2021

Primary Completion Date

November 2, 2021

Study Completion Date

January 20, 2022

Conditions
COVID-19
Interventions
DIETARY_SUPPLEMENT

NLC-V

NLC-V

Trial Locations (1)

Unknown

Shaare Zedek Hospital, Jerusalem

All Listed Sponsors
lead

Todos Medical, Ltd.

INDUSTRY

NCT05226767 - Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19 | Biotech Hunter | Biotech Hunter